Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania
Guy Hutton, David Schellenberg, Fabrizio Tediosi, Eusebio Macete, Elizeus Kahigwa, Betuel Sigauque, Xavier Mas, Marta Trapero, Marcel Tanner, Antoni Trilla, Pedro Alonso & Clara Menendez
Volume 87, Number 2, February 2009, 123-129
Table 3. Cost-effectiveness of malaria IPTi in a study in Mozambique (Manhiça) and the United Republic of Tanzania (Ifakara), 2006
|Cost-effectiveness ratiosa and ranges from Monte-Carlo simulation
|Using individual efficacy results|
|Cost per DALY averted||3.7 (1.6–12.2)||11.2 (3.6–92.0)|
|Cost per malaria episode averted||1.6 (0.8–4.0)||4.7 (1.7–30.3)|
|Cost per malaria death averted||100.2 (43.0–330.9)||301.1 (95.6–2498.4)|
|Using pooled efficacy results|
|Cost per DALY averted||7.9 (3.2–27.0)||8.3 (3.3–27.5)|
|Cost per malaria episode averted||3.3 (1.4–10.3)||3.5 (1.6–11.0)|
|Cost per malaria death averted||211.0 (84.5–730.2)||222.8 (88.6–747.1)|
DALY, disability-adjusted life year; ITPi, intermittent preventive treatment in infants.
a Ratios represent the estimated aggregate effect of the IPTi intervention divided by the estimated aggregate cost (US$) of providing the intervention for a reference target population of 1000 immunized infants. The cost portion of the cost-effectiveness ratio includes only intervention costs; cost savings from fewer malaria cases are excluded.